BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15213237)

  • 1. BCL10 mediates lipopolysaccharide/toll-like receptor-4 signaling through interaction with Pellino2.
    Liu Y; Dong W; Chen L; Xiang R; Xiao H; De G; Wang Z; Qi Y
    J Biol Chem; 2004 Sep; 279(36):37436-44. PubMed ID: 15213237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The IRAK-1-BCL10-MALT1-TRAF6-TAK1 cascade mediates signaling to NF-kappaB from Toll-like receptor 4.
    Dong W; Liu Y; Peng J; Chen L; Zou T; Xiao H; Liu Z; Li W; Bu Y; Qi Y
    J Biol Chem; 2006 Sep; 281(36):26029-40. PubMed ID: 16831874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipopolysaccharide activates NF-kappaB by TLR4-Bcl10-dependent and independent pathways in colonic epithelial cells.
    Bhattacharyya S; Dudeja PK; Tobacman JK
    Am J Physiol Gastrointest Liver Physiol; 2008 Oct; 295(4):G784-90. PubMed ID: 18718996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bcl10 mediates LPS-induced activation of NF-kappaB and IL-8 in human intestinal epithelial cells.
    Bhattacharyya S; Borthakur A; Pant N; Dudeja PK; Tobacman JK
    Am J Physiol Gastrointest Liver Physiol; 2007 Aug; 293(2):G429-37. PubMed ID: 17540779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex.
    Youn HS; Lee JY; Fitzgerald KA; Young HA; Akira S; Hwang DH
    J Immunol; 2005 Sep; 175(5):3339-46. PubMed ID: 16116226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cooperation of Toll-like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein A lipoprotein: role of Toll-interacting protein and IL-1 receptor signaling molecules in Toll-like receptor 2 signaling.
    Bulut Y; Faure E; Thomas L; Equils O; Arditi M
    J Immunol; 2001 Jul; 167(2):987-94. PubMed ID: 11441107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells.
    Paik YH; Schwabe RF; Bataller R; Russo MP; Jobin C; Brenner DA
    Hepatology; 2003 May; 37(5):1043-55. PubMed ID: 12717385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipopolysaccharide-induced activation of NF-κB non-canonical pathway requires BCL10 serine 138 and NIK phosphorylations.
    Bhattacharyya S; Borthakur A; Dudeja PK; Tobacman JK
    Exp Cell Res; 2010 Nov; 316(19):3317-27. PubMed ID: 20466000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dok-1 and Dok-2 are negative regulators of lipopolysaccharide-induced signaling.
    Shinohara H; Inoue A; Toyama-Sorimachi N; Nagai Y; Yasuda T; Suzuki H; Horai R; Iwakura Y; Yamamoto T; Karasuyama H; Miyake K; Yamanashi Y
    J Exp Med; 2005 Feb; 201(3):333-9. PubMed ID: 15699069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chlamydial heat shock protein 60 activates macrophages and endothelial cells through Toll-like receptor 4 and MD2 in a MyD88-dependent pathway.
    Bulut Y; Faure E; Thomas L; Karahashi H; Michelsen KS; Equils O; Morrison SG; Morrison RP; Arditi M
    J Immunol; 2002 Feb; 168(3):1435-40. PubMed ID: 11801686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction.
    Chow JC; Young DW; Golenbock DT; Christ WJ; Gusovsky F
    J Biol Chem; 1999 Apr; 274(16):10689-92. PubMed ID: 10196138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRIP6 is a RIP2-associated common signaling component of multiple NF-kappaB activation pathways.
    Li L; Bin LH; Li F; Liu Y; Chen D; Zhai Z; Shu HB
    J Cell Sci; 2005 Feb; 118(Pt 3):555-63. PubMed ID: 15657077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mouse toll-like receptor 4.MD-2 complex mediates lipopolysaccharide-mimetic signal transduction by Taxol.
    Kawasaki K; Akashi S; Shimazu R; Yoshida T; Miyake K; Nishijima M
    J Biol Chem; 2000 Jan; 275(4):2251-4. PubMed ID: 10644670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppressor of cytokine signaling (SOCS) proteins indirectly regulate toll-like receptor signaling in innate immune cells.
    Baetz A; Frey M; Heeg K; Dalpke AH
    J Biol Chem; 2004 Dec; 279(52):54708-15. PubMed ID: 15491991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of MyD88 and TLR4 in the LPS-mimetic activity of Taxol.
    Byrd-Leifer CA; Block EF; Takeda K; Akira S; Ding A
    Eur J Immunol; 2001 Aug; 31(8):2448-57. PubMed ID: 11500829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction.
    Fitzgerald KA; Palsson-McDermott EM; Bowie AG; Jefferies CA; Mansell AS; Brady G; Brint E; Dunne A; Gray P; Harte MT; McMurray D; Smith DE; Sims JE; Bird TA; O'Neill LA
    Nature; 2001 Sep; 413(6851):78-83. PubMed ID: 11544529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The E3 ubiquitin ligase mind bomb-2 (MIB2) protein controls B-cell CLL/lymphoma 10 (BCL10)-dependent NF-κB activation.
    Stempin CC; Chi L; Giraldo-Vela JP; High AA; Häcker H; Redecke V
    J Biol Chem; 2011 Oct; 286(43):37147-57. PubMed ID: 21896478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reciprocal modulation of Toll-like receptor-4 signaling pathways involving MyD88 and phosphatidylinositol 3-kinase/AKT by saturated and polyunsaturated fatty acids.
    Lee JY; Ye J; Gao Z; Youn HS; Lee WH; Zhao L; Sizemore N; Hwang DH
    J Biol Chem; 2003 Sep; 278(39):37041-51. PubMed ID: 12865424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of soluble form of recombinant extracellular TLR4 domain with MD-2 enables lipopolysaccharide binding and attenuates TLR4-mediated signaling.
    Hyakushima N; Mitsuzawa H; Nishitani C; Sano H; Kuronuma K; Konishi M; Himi T; Miyake K; Kuroki Y
    J Immunol; 2004 Dec; 173(11):6949-54. PubMed ID: 15557191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct pathways of LPS-induced NF-kappa B activation and cytokine production in human myeloid and nonmyeloid cells defined by selective utilization of MyD88 and Mal/TIRAP.
    Andreakos E; Sacre SM; Smith C; Lundberg A; Kiriakidis S; Stonehouse T; Monaco C; Feldmann M; Foxwell BM
    Blood; 2004 Mar; 103(6):2229-37. PubMed ID: 14630816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.